Selective carotid body ablation in experimental heart failure: A new therapeutic tool to improve cardiorespiratory control

Experimental Physiology

Volumn 100, Issue 2, 2015, Pages 136-142

  Del Rio, Rodrigo ^a   Andrade, David C ^a,b   Marcus, Noah J ^c   Schultz, Harold D ^c  

^a UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APNEA; ARTICLE; AUTONOMIC DYSFUNCTION; BREATHING; BREATHING DISORDER; CARDIOVASCULAR RISK; CAROTID BODY ABLATION; CAROTID BODY CHEMORECEPTOR; CHEMORECEPTOR REFLEX; CHEMOSENSITIVITY; DENERVATION; DETERIORATION; EXPERIMENTAL HEART FAILURE; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART RATE VARIABILITY; MORTALITY; NONHUMAN; PRESSORECEPTOR REFLEX; RAT; RESPIRATION CONTROL; SURVIVAL RATE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CAROTID BODY; HEART; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CAROTID BODY; HEART; HEART FAILURE; HUMANS; REFLEX; RESPIRATION;

EID: 84921821012     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.079566     Document Type: Article

References (30)

1. Bradley TD & Floras JS (2003a). Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107, 1671-1678.
2. Bradley TD & Floras JS (2003b). Sleep apnea and heart failure: Part II: central sleep apnea. Circulation 107, 1822-1826.
3. Cohn JN, Ferrari R & Sharpe N (2000). Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35, 569-582.
4. Chua TP, Clark AI, Amadi AA & Coats AJS (1996). Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27, 650-657.
5. Chugh SS, Chua TP & Coats AJ (1996). Peripheral chemoreflex in chronic heart failure: friend and foe. Am Heart J 132, 900-904.
6. Del Rio R, Marcus NJ & Schultz HD (2013a). Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 62, 2422-2430.
7. Del Rio R, Marcus NJ & Schultz HD (2013b). Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure. J Appl Physiol 114, 1141-1150.
8. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard J-M, Lambert G, Esler M & Pathak A (2012). Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 30, 753-760.
9. Du X-J, Cox HS, Dart AM & Esler MD (1999). Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res 43, 919-929.
10. Francis J (2001). Progression of heart failure after myocardial infarction in the rat. Am J Physiol Reg Int Comp Physiol 281, R1734-R1745.
11. Giannoni A, Emdin M, Poletti R, Bramanti F, Prontera C, Piepoli M & Passino C (2008). Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci (Lond) 114, 489-497.
12. Haack KK, Marcus NJ, Del Rio R, Zucker IH & Schultz HD (2014). Simvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure. Hypertension 63, 1041-1049.
13. Hanly PJ & Zuberi-Khokhar NS (1996). Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153, 272-276.
14. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A & Schwartz PJ (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478-484.
15. Leung RS, Floras JS, Lorenzi-Filho G, Rankin F, Picton P & Bradley TD (2003). Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med 167, 1534-1539.
16. Li YL, Li YF, Liu D, Cornish KG, Patel KP, Zucker IH, Channon KM & Schultz HD (2005). Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ Res 97, 260-267.
17. Meredith IT, Broughton A, Jennings GL & Esler MD (1991). Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325, 618-624.
18. Niewiński P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart ECJ, Paton JFR & Ponikowski P (2013). Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol 168, 2506-2509.
19. Peng YJ, Nanduri J, Khan SA, Yuan G, Wang N, Kinsman B, Vaddi DR, Kumar GK, Garcia JA, Semenza GL, Prabhakar NR (2011) Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci USA 108, 3065-3070.
20. Pfeffer MA & Braunwald E (1990). Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161-1172.
21. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF & Coats AJ (2001). Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104, 544-549.
22. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A & Coats AJS (1997). Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96, 2586-2594.
23. Porter TR, Eckberg DL, Fritsch JM, Rea RF, Beightol LA, Schmedtje JF Jr & Mohanty PK (1990). Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest 85, 1362-1371.
24. Schultz HD, Li YL & Ding Y (2007). Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50, 6-13.
25. Schultz HD & Sun SY (2000). Chemoreflex function in heart failure. Heart Fail Rev 5, 45-56.
26. Solin P, Roebuck T, Johns DP, Walters EH & Naughton MT (2000). Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162, 2194-2200.
27. Sun S, Wang W, Zucker IH & Schultz HD (1999a). Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86, 1273-1282.
28. Sun S, Wang W, Zucker IH & Schultz HD (1999b). Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86, 1264-1272.
29. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G & Butler J (2009). The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54, 1747-1762.
30. Trzebski A (1992). Arterial chemoreceptor reflex and hypertension. Hypertension 19, 562-566.